Source:http://linkedlifedata.com/resource/pubmed/id/18627205
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2008-7-16
|
pubmed:abstractText |
The purpose of this article is to review immunization recommendations for HIV-infected individuals in resource-constrained countries, particularly in sub-Saharan Africa. Recent evidence suggests that HIV-infected children are at risk for low immunization coverage in sub-Saharan Africa. Routine immunization is recommended for these children. In comparison with immunocompetent children, recommendations for live-attenuated vaccines differ in HIV-infected children. However, limited laboratory capacity to diagnose HIV infection amongst young children prevents the implementation of these HIV-specific guidelines in resource-constrained countries. Re-immunization has been the focus of recent research in high- and middle-income countries. Findings show that children established on highly active antiretroviral therapy have suboptimal vaccine-specific immunity and may benefit from re-immunization. Before re-immunization guidelines can be formulated for resource-constrained countries, several questions should be addressed, including whether all HIV-infected children will benefit from routine re-immunization and what optimal number of vaccine doses should be administered. Pneumococcal and influenza infections are important causes of morbidity and mortality amongst HIV-infected individuals. There is compelling evidence showing that pneumococcal conjugate vaccines will protect HIV-infected and uninfected children against invasive infection. Pneumococcal conjugate vaccines should be prioritized for introduction in countries with high HIV prevalence. Although, annual influenza immunization is recommended for HIV-infected individuals, the effectiveness in Africa remains unclear. In conclusion, this brief overview has identified several limitations of current immunization policy and practice for HIV-infected individuals living in resource-constrained countries.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0012-6667
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1473-81
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:18627205-Africa South of the Sahara,
pubmed-meshheading:18627205-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:18627205-Bacterial Infections,
pubmed-meshheading:18627205-Bacterial Vaccines,
pubmed-meshheading:18627205-Child,
pubmed-meshheading:18627205-HIV Infections,
pubmed-meshheading:18627205-Humans,
pubmed-meshheading:18627205-Mass Vaccination,
pubmed-meshheading:18627205-Practice Guidelines as Topic,
pubmed-meshheading:18627205-Viral Vaccines,
pubmed-meshheading:18627205-Virus Diseases
|
pubmed:year |
2008
|
pubmed:articleTitle |
Immunization in patients with HIV infection: are practical recommendations possible?
|
pubmed:affiliation |
Paediatric Infectious Diseases Unit, Red Cross Children's Hospital, School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa. Brian.Eley@uct.ac.za
|
pubmed:publicationType |
Journal Article,
Review
|